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ABSTRACT
JWA was recently demonstrated to be involved in
cellular responses to environmental stress including
oxidative stress. Although it was found that JWA
protected cells from reactive oxygen species-
induced DNA damage, upregulated base excision
repair (BER) protein XRCC1 and downregulated
PARP-1, the molecular mechanism of JWA in regu-
lating the repair of DNA single-strand breaks (SSBs)
is still unclear. Our present studies demonstrated
that a reduction in JWA protein levels in cells
resulted in a decrease of SSB repair capacity and
hypersensitivity to DNA-damaging agents such as
methyl methanesulfonate and hydrogen peroxide.
JWA functioned as a repair protein by multi-
interaction with XRCC1. On the one hand, JWA
was translocated into the nucleus by the carrier pro-
tein XRCC1 and co-localized with XRCC1 foci after
oxidative DNA damage. On the other hand, JWA via
MAPK signaling pathway regulated nuclear factor
E2F1, which further transcriptionally regulated
XRCC1. In addition, JWA protected XRCC1 protein
from ubiquitination and degradation by proteasome.
These findings indicate that JWA may serve as
a novel regulator of XRCC1 in the BER protein
complex to facilitate the repair of DNA SSBs.
INTRODUCTION
Viable cells suﬀer spontaneous DNA damage or can be
damaged as a result of environmental exposure to a vari-
ety of insults. DNA single-strand breaks (SSBs) are one
of the commonest DNA lesions, arising either indirectly
during DNA base excision repair (BER) through
enzymatic incision of an abasic site (AP) by apurinic/apyr-
idinic endonuclease 1 (APE1) or a dual-function DNA
glycosylase, or directly from deoxyribose damage due to
reactive oxygen species (ROS) or from abortive top1 activ-
ity (1–3). If SSBs are not properly repaired, they may
result in genetic instability, higher frequency of chromo-
somal aberrations (4,5) and conversion into DNA
double-strand breaks (DSBs) during DNA replication
(6), eventually leading to subsequent tumorigenesis (7,8).
The pathways for SSB repair (SSBR) in mammalian
cells involve four basic steps which include damage detec-
tion, end processing, gap ﬁlling and DNA ligation (2,9).
During the ﬁrst step, one of the earliest responses to DNA
strand breakage is the induction of poly (ADP-ribose)
(PAR) synthesis (10,11). When DNA SSBs are present,
PARP-1 rapidly binds to the DNA strand breaks and is
activated, covalently automodifying itself and, to a lesser
extent, other acceptor proteins with long chains of PAR
(10,12,13). This step is required for cellular SSBs to
recruit, stabilize or accumulate the scaﬀold protein,
XRCC1 (14,15), which then mediates multiple interactions
with enzymatic components of the repair process. For
example, XRCC1 appears to interact with APE1 (16)/
DNA polymerase b (17) and DNA polynucleotide
kinase (PNK) (18)/PCNA (19), which play important
roles in end processing and gap ﬁlling, respectively (9).
XRCC1 also interacts with DNA ligase IIIa (20), which
seals single nucleotide nicks in the process of BER (21,22).
Substantial evidence indicates that XRCC1 plays a crit-
ical role in SSBR. XRCC1-deﬁcient cells (EM9 or EM11)
are hypersensitive to DNA damage induced by alkylating
agents, ROS or ionizing radiation (23–25). Additionally,
these cells display increased rates of spontaneous sister-
chromatid exchange and chromosomal aberrations
(4,5,23). Furthermore, downregulation of XRCC1 expres-
sion in human breast cancer cell lines by RNA interference
(RNAi) also resulted in decreased SSBR capacity and
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LigIII, which is stabilized by XRCC1, is also required
for SSBR (27). It was shown that LigIII mutant cells
possess relatively normal XRCC1 levels, but have an ele-
vated frequency of sister-chromatid exchange (SCE) (27).
Deﬁciency in either XRCC1 or LigIII results in embryonic
lethality in mice (27–29).
Recent studies have helped clarify how DNA damage
leads to changes in XRCC1 transcription or translation.
Yacoub et al. (30) demonstrated that XRCC1 mRNA and
protein levels were increased after DNA damage through
activation of MAPK signaling cascades. E2F1, an active
transcriptional factor located downstream of the MAPK
signaling pathway (31,32), can bind the XRCC1 promoter
to regulate XRCC1 transcription, which facilitates the
SSBR/BER (33). However, there is a striking check
point mechanism present in mammalian cells to ensure
that the XRCC1 protein is maintained at the necessary
level (34,35). XRCC1 is ubiquitylated by the E3 ubiquitin
ligase CHIP and subsequently degraded through the
ubiquitin-proteasome pathway (34).
The JWA gene, also known as ARL6ip5, was initially
cloned from human tracheal bronchial epithelial cells
after treatment with all-trans retinoic acid (36).
Subsequent studies indicated that JWA is a structurally
novel microtubule-associated protein, which regulates
cancer cell migration via MAPK cascades (37) and med-
iates diﬀerentiation of leukemic cells (38,39). JWA is also
involved in the cellular responses to heat shock and che-
mical-mediated oxidative stresses (40,41). Moreover, JWA
plays a key role in protecting cells from DNA damage
induced by oxidative stress, as evidenced by the increase
in the level of BER protein XRCC1 and the reduction in
PARP-1 expression (42). However, the underlying
mechanisms by which JWA regulates XRCC1 are unclear.
Herein, we provide additional evidence conﬁrming that
JWA is necessary for cell survival and eﬃcient DNA
repair after oxidative DNA damage. Further mechanistic
studies have demonstrated that JWA translocates into the
nucleus and co-localizes with XRCC1 foci after oxidative
DNA damage. In addition, JWA regulates XRCC1
expression at both the transcriptional and post-transla-
tional levels. These observations identify a role for JWA
in DNA SSBR/BER pathway and provide a novel mech-
anism of JWA-mediated regulation of XRCC1 expression.
MATERIALS AND METHODS
Cell culture
NIH-3T3, HELF cells were purchased from the Shanghai
Institute of Biochemistry and Cell Biology, Chinese
Academy of Sciences (Shanghai, China). Cells were cul-
tured in Dulbecco’s modiﬁed Eagle’s medium supplemen-
ted with 100U/ml penicillin, 100mg/ml streptomycin and
10% fetal bovine serum. The cells were grown at 378Ci n
the presence of 5% CO2 in a humidiﬁed incubator.
Plasmids and reagents
The EGFP-C1-antisense JWA and pEGFP-C1-JWA
expression plasmids were described previously (37,42).
The JWA siRNA Expression Cassette and scrambled
short-hairpin RNA (shRNA) (39) were subcloned into
the linearized vector pSEC (Ambion, Austin, TX, USA)
to produce JWA shRNA and control shRNA plasmids,
respectively. The identity of the plasmids was conﬁrmed
by DNA sequencing. The remaining plasmids were
obtained from other investigators, including pGL3-
XRCC1 (–881 to +158) and pGL3-XRCC1 (–766 to
+158) luciferase-reporter plasmids (Prof. Charles D.
Lopez, Oregon Health and Science University, USA),
and RFP-XRCC1 (Prof. Heinrich Leonhardt, Ludwig
Maximilians University, Germany). XRCC1 siRNA or
scramble control siRNA were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). MMS, cycloheximide
(CHX), MG132 and 3-aminobenzamide (3-AB) were pur-
chased from Sigma–Aldrich (St Louis, MO, USA). U0126
and PD98059 were purchased from Cell Signaling
Technology (Beverly, MA, USA).
Stable ortransient transfections
Transfections of the pEGFP-C1-antisense-JWA plasmid
and the pEGFP-C1 vector control plasmid into the
NIH-3T3 and HELF cells were carried out using
Lipofectamine 2000 transfection reagent (Invitrogen,
Shanghai, China) following the manufacturer’s protocol.
The cells were selected with G418at a ﬁnal concentration
of 500mg/ml or 400mg/ml for NIH-3T3 cells or HELF cells,
respectively. The resulting NIH-3T3 and HELF cells were
veriﬁed to possess stable knockdown of JWA expression
(KD-JWA) or to express the control vector. For transient
transfections, plasmid DNA or siRNA were transfected
into cells with Lipofectamine 2000 according to manufac-
turer’s instruction.
Luciferase reporter gene assays and host-cell-reactivation
(HCR) assay
Cells were seeded onto 24-well plates (1 10
5 cells per
well), and co-transfected with 2.25mg of pGL3-XRCC1
(–881 to +158) or pGL3-XRCC1 (–766 to+158) lucifer-
ase-reporter plasmid, together with the JWA shRNA or
control shRNA plasmid with Lipofectamine 2000. All the
plasmids were co-transfected with 10ng of pRL-SV40,
which contains the Renilla luciferase gene. Forty-eight
hours after transfection, the cells were treated with
100mMH 2O2 for 30min, then washed once with PBS
and harvested. Cell lysates were prepared according to
Promega’s instruction manual. Luciferase activity was
measured with a dual-Luciferase Reporter Assay System
(Promega, Madison, WI, USA) and the activity was nor-
malized against the Renilla luciferase gene.
The HCR assay was used to measure the DNA repair
capacity (DRC) (43,44). The pGL3-control luciferase
vector (LUC
con) (Promega, Madison, WI, USA) back-
bone containing the SV40 promoter and enhancer
sequences was used. The LUC
con DNA was oxidatively
damaged in vitro by dilution to 50mg/ml and exposure
to the indicated concentration of H2O2 (v/v) at room
temperature for 1h. Undamaged control plasmids were
treated with the vehicle solutions without exposure to
the damaging agents. After all treatments, the damaged
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tion, and resuspended in TE buﬀer (pH 7.8) at a ﬁnal
concentration of 500mg/ml. NIH-3T3 cells were then
transfected with the damaged or undamaged LUC
con plas-
mids. The methods for transfection and luciferase activity
measurement were the same as used in the luciferase
reporter assay described above. DRC (%) was calculated
as the ratio of the damaged plasmid luciferase activity
to the undamaged plasmid luciferase activity, multiplied
by 100%.
Survivalcurves and determination of intracellular NAD(P)H
Cells were plated into 96-well plates (3000–5000 cells/
well). The next day, the cells were exposed to H2O2 for
30min or MMS for 1h at the indicated concentrations in
complete medium at 378C. After washing with PBS, cells
were further incubated for 3 days in drug-free medium.
Cell viability was measured using the MTT assay as
described (41). All measurements were done in triplicate
and experiments were repeated at least twice.
Depletion of intracellular NAD(P)H was monitored
as the described method (45) using a CCK-8 solution
(Dojindo Laboratories, Kumamoto, Japan). Brieﬂy, cells
were seeded into 96-well plates for 24h, then treated with
H2O2 or MMS at the indicated concentrations, and
1/10vol of CCK-8 solution in the presence or absence of
10mM 3-aminobenzamide (3-AB) was added to each well
(Sigma). Visible absorbance at 450 and 600nm as a refer-
ence ﬁlter was measured 4h after the start of the treat-
ment. Measurements were done in triplicate, and error
bars represent the standard deviation of six parallel mea-
surements of one typical experiment.
Indirect immunofluorescent microscopy
Cells were grown on coverslips, rinsed in PBS and treated
with 10mM H2O2 in PBS at room temperature for 20min
at 378C, then incubated in drug-free medium for 10min.
Coverslips were rinsed in PBS and ﬁxed with 4% formal-
dehyde in PBS for 20min at 48C. Cells were permeabilized
with PBS containing 0.01% Triton X-100 and 0.05% SDS,
pH 7.4 for 5min at 48C. Permeabilized cells were rinsed in
PBS supplemented with 0.5% Tween-20 (PBST), and cells
were blocked with blocking solution (0.1% saponin and
0.2% BSA in PBS, pH 7.4) for 1h. Cells were rinsed in
PBST three times and incubated with either a mixture of
anti-JWA rabbit polyclonal antibody (1:200 dilution in
PBST; Research Genetics Inc., S.W. Huntsville, AL) and
anti-poly (ADP-ribose) mouse monoclonal antibody
(Chemicon; 1:200 dilution in PBST) overnight at 48C, or
a mixture of anti-JWA rabbit polyclonal antibody (1:200
dilution in PBST) and anti-XRCC1 mouse monoclonal
antibody (NeoMarkers; 1:200 dilution in PBST). After
rinsing in PBST, coverslips were incubated in a mixture
of Texas red-conjugated anti-rabbit IgG secondary
antibody or ﬂuorescein isocyanate (FITC)-conjugated
anti-mouse IgG secondary antibody (KPL, Inc.,
Gaithersburg, MD, USA), at a 1:200 dilution in PBST
for 1h at 378C. Cell nuclei were counterstained with
0.000025% 40,6 0-diamidino-2-phenylindole (DAPI). The
intracellular distributions of the target proteins were
analyzed using confocal ﬂuorescent microscopy.
Confocal images were sequentially acquired with Zeiss
AIM software on a Zeiss LSM 510 confocal microscope
system (Carl Zeiss Inc, Thornwood, NY, USA) with exci-
tation at 488nm (for FITC), 543nm (for Texas red) and
340nm (for DAPI).
Quantitative real-time RT-PCR assay
NIH-3T3 cells were transiently transfected with either the
JWA shRNA plasmid or control shRNA vector. Forty-
eight hours later, the cells were cultured with or without
100mMH 2O2 for 30min. Total RNA was extracted from
the cells using the Trizol reagent (Gibco BRL,
Gaithersburg MD, USA). Approximately 1mg of RNA
was used for the reverse transcription reaction with
OligodT (18T) (Invitrogen). The cDNA was ampliﬁed
with the following primers: 50-GCCGGTGCTGAGTAT
GTC-30 (forward) and 50-CTTCTGGGTGGCAGT
GAT-30 (reverse) for GAPDH;5 0-CTTTGTGGAGGTG
CTAGTGG-30 (forward) and 50-ATGGCGAGTCCTTG
CTGT-30 (reverse) for XRCC1;5 0-GGAGGAGTCATTG
TGGTGC-30 (forward) and 50-GAAGTCTCAGGGATG
CGTG-30 (reverse) for JWA.
Quantitative real-time PCR was carried out on the
Light Cycler System using the double-strand DNA-
binding dye evaGreen (Biotium Hayward, CA, USA) for
the detection of PCR products. The following thermal
cycling conditions were used: denaturation, 948C for
5min followed by 44 cycles of denaturation at 948C for
35s, annealing at 568C (for JWA and XRCC1)o r5 9 8C
(for GAPDH) for 30s and extension at 728C for 35s. The
cycles were followed by a ﬁnal extension step at 728C for
8min, and melting curves from 708Ct o9 0 8C were deter-
mined. The ﬂuorescence intensity of the evaGreen was
read on the Light Cycler System after the end of each
extension step. Data were expressed as the number of
cycle thresholds (Ct), the PCR cycle number at which
the ﬂuorescent signal in each reaction reached a preset
threshold above the background. A melting curve was
created using the built-in melting curve program to con-
ﬁrm the presence of a single PCR product. GAPDH
mRNA was used as an internal control for each sample,
and the Ct value for each sample was normalized to
GAPDH mRNA.
Subcellular fractionation and western blotting analysis
Nuclear extracts were obtained using the NE-PER
Nuclear and Cytoplasmic Extraction Reagents (Pierce
Biotechnology, Rockford, IL, USA). Total cell lysates
were prepared with a detergent lysis buﬀer [50mM Tris
(pH 7.4), 150mM NaCl, 1% NP-40, 0.5% sodium deox-
ycholate, 0.1% SDS, 1mM PMSF]. Western blots were
performed as previously reported (32). For each treatment
group, three parallel samples were applied, and equal
amounts of proteins from the parallel samples were
mixed and used for blots.
The antibodies used were the monoclonal anti-XRCC1
(1:1000) (Abcam, Cambridge, UK); polyclonal anti-
poly (ADP-ribose) polymerase-1 (PARP-1) (1:500), anti-
aldolase (1:500), anti-histone H1 (1:500), monoclonal
1938 Nucleic Acids Research, 2009, Vol. 37,No. 6anti-ubiquitin (1:500), anti-E2F1 (1:500) (Santa Cruz
Biotechnology); polyclonal anti-phospho-p44/42 MAPK
(Thr202/Tyr204) (1:1000), anti-p44/42 MAPK (ERK1/2)
(1:1000) (Cell Signaling Technology, Beverly, MA, USA);
monoclonal anti-LigIII (1:1000) (BD Transduction
Laboratories, San Diego, CA, USA); polyclonal goat
anti-JWA (1:1000) (Imgenex, San Diego, CA, USA) and
polyclonal anti-b-actin (1:1000) (Boster Biotechnology,
Wuhan, China). Each blot was repeated three times.
b-Actin was used for the protein loading control, whereas
aldolase and histone H1 were used for the cytoplasmic and
nuclear controls, respectively.
Electrophoretic mobility shiftassays (EMSAs)
EMSAs were performed with a Biotin Gel Shift Kit
(Pierce, Rockford, IL, USA), as described previously
(42). Brieﬂy, binding reactions were performed by
adding 0.5 or 1mg of the nuclear extracts to a mixture
containing 40fmol of biotin 30-end-labeled, double-
stranded probes: (50-TAA TTT TTT TCG CGC GTG
CGC GCG CGC GTA-30) (underlined sequences indicate
putative E2F1-binding sites) in 20ml of binding buﬀer
[100mM HEPES (pH 7.6), 5mM EDTA, 50mM
(NH4)2SO4, 5mM dithiothreitol (DTT), 1% Tween-20,
150mM MgCl2,1 mg/ml poly(dI–dC), 0.1mg/ml L-lysine].
For supershift experiments, 1mg of monoclonal E2F1
antibody was added to aliquots of the extracts, and incu-
bated for 20min on ice before addition of the reaction
mixture. Competition reaction mixtures contained a
100-fold molar excess of nonlabeled double-stranded
oligoDNAs or mutated nonlabeled double-stranded
oligoDNAs: (50-TAA TTT TCG AGC TGC GTAG A C
TCA CGC GTA-30) (mutated nucleotides in putative
E2F1-binding sites in italic and bold). The DNA–protein
complexes were separated on a native 4.5% polyacryla-
mide gel at 100V and then transferred onto a nylon mem-
brane. The positions of the biotin end-labeled
oligonucleotides were detected by a chemiluminescent
reaction according to the manufacturer’s instructions
(Pierce) and visualized by autoradiography.
Co-immunoprecipitation
NIH-3T3 cells were grown to conﬂuence and processed for
co-immunoprecipitation by standard procedures described
previously (32). Brieﬂy, the cells were harvested and lyzed
in cold lysis buﬀer [50mM Tris (pH 7.4), 150mM NaCl,
1mM EDTA, 0.5% (v/v) NP-40, 10% (v/v) glycerol,
1mM PMSF]. The cell extracts were centrifuged at
12000g at 48C for 15min, and the supernatant was then
incubated with protein A/G agarose beads or control IgG
(Santa Cruz) as a pretreatment. Precleared lysates were
then incubated with anti-PARP-1 polyclonal antibody,
anti-JWA polyclonal antibody, anti-LigIII monoclonal
antibody, anti-XRCC1 monoclonal antibody or control
IgG for 1h, then incubated overnight with protein A/G
agarose beads. The beads were collected by centrifugation,
washed three times with the lysis buﬀer and resuspended
in 1 SDS loading buﬀer. The immunoprecipitates were
eluted from the beads by incubation at 958C for 5min.
The eluted proteins were separated by SDS–PAGE and
western blotting was subsequently performed with indi-
cated antibodies.
Statistical analysis
Data were expressed as the means SD. Two-factor ana-
lysis of variance procedures and the Dunnett’s t-test were
used to assess diﬀerences within treatment groups.
Diﬀerences were considered signiﬁcant when P<0.05.
RESULTS
JWAisrequired forDNA repair following oxidative stress
Chen et al. (42) previously showed that the DNA damage
in JWA knockdown cells was greater than that in vector
control cells as determined using the comet assay. JWA
knockdown also decreased the DNA repair frequency fol-
lowing damage induced by oxidative stress. The alkaline
comet assay can thus be used to intuitively observe
damaged DNA under ﬂuorescent microscopy. However,
alkylating agents and oxidants were also reported to
induce either alkaline-labile base lesions or AP sites lead-
ing to SSBs under basic conditions (46).
Studies were undertaken to determine if endogenous
JWA plays a physiological role in the repair of H2O2-
induced DNA lesions. The HCR assay, which was
previously validated in a study of BER proteins and
H2O2-induced DNA lesions (44), was conducted in this
study. First, a dose-repair model for the LUC
con plasmid
was performed, and then the DRC was determined for the
plasmids damaged by H2O2. The DRC was reduced to
 55% for 10% (v/v) H2O2-treated LUC
con plasmids com-
pared to undamaged control plasmids (Figure 1A). In
NIH-3T3 cells, the JWA protein level was signiﬁcantly
reduced by  97% after transient transfection with JWA
shRNA (Figure 1B). Subsequently, the eﬀect of JWA in
NIH-3T3 cells was examined by HCR assay, and it was
found that the DRC was reduced by more than 80% in
JWA-knockdown cells compared to cells transfected with
the control vector (Figure 1D). In contrast, overexpression
of JWA in the NIH-3T3 cells markedly increased the DRC
by up to 2-fold (Figure 1C and D).
To conﬁrm the requirement for JWA in DNA damage
repair, additional SSBR endpoints were investigated.
Cell survival for 72h was determined by MTT assay
after induction of DNA damage by H2O2 or MMS.
Stable transfection to knockdown JWA expression was
conducted in two cell lines (KD-JWA NIH-3T3 and
KD-JWA HELF) and the loss of JWA was determined
by western blot analysis. We observed that JWA protein
levels were reduced by 85% or 90% in KD-JWA NIH-3T3
or HELF cells compared to the vector control cells
(Figure 2A). Compared to the control cells, both
KD-JWA NIH-3T3 and KD-JWA HELF cells showed
signiﬁcantly greater sensitivity to H2O2 and MMS,
which causes SSBs in DNA (Figure 2B). These data indi-
cate an important role for endogenous JWA in SSBR/
BER of oxidative-stress-induced DNA lesions.
Next, we measured the activity of PARP-1 by quantify-
ing intracellular NAD(P)H, which is also a reliable index
to monitor the imbalance in DNA-strand break repair in
Nucleic Acids Research,2009, Vol.37, No. 6 1939BER-deﬁcient cells (45). We demonstrated that JWA
knockdown caused an enhanced reduction of intracellular
NAD(P)H in both NIH-3T3 and HELF cells in response
to MMS or H2O2 (Figure 2C). The presence of 3-AB, a
speciﬁc PARP-inhibitor, almost completely blocked the
DNA-damage-induced decrease in NAD(P)H in all
tested cells, suggesting that the observed NAD(P)H deple-
tion is due to increased PARP-1 activation. The trypan
blue exclusion assay demonstrated no signiﬁcant diﬀer-
ences in cell viability at the noted MMS or H2O2 concen-
trations, indicating that the depletion of NAD(P)H is not
due to a reduction in the number of viable cells (data not
shown). Additionally, our data indicate that there was
a greater deﬁciency in SSB repair in the JWA-deﬁcient
cells than in the control cells.
JWAasanovelBERproteinisinvolvedintheSSBRpathway
Our previous studies indicated that XRCC1 protein
levels were regulated by JWA under oxidative stress con-
ditions (42). To elucidate if JWA is involved in the
XRCC1-associated signaling pathways, JWA knockdown
NIH-3T3 cells and control cells were treated with 100mM
H2O2 for 30min, and then cultured in H2O2-free medium
to allow for DNA rejoining. In the cells transfected with
the control vector, the levels of XRCC1, LigIII and JWA
all gradually increased for the ﬁrst 30min during repair,
then returned to almost normal by 1h. The levels of
XRCC1 and LigIII were downregulated in the JWA
knockdown NIH-3T3 cells, while no change in APE1 pro-
tein (upstream of XRCC1) level was observed in JWA
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Figure 2. JWA-knockdown cells are hypersensitive to DNA-damaging agents. (A) JWA expression was decreased in KD-JWA NIH-3T3 cells (top
panel) or HELF cells (bottom panel) compared with vector control cells. (B) JWA knockdown enhances the cell death induced by DNA-damaging
agents (MMS and H2O2). Vector control and KD-JWA NIH-3T3 or HELF cells were treated with the indicated doses of H2O2 for 30min or MMS
for 1h, then the cells were incubated for further 72h in drug-free medium. Cell survival was determined using the MTT assay. The relative%
surviving cells are presented as the means   SD of three independent samples. (C) Intracellular NAD(P)H levels in living cells (vector control and
KD-JWA cells) were determined by CCK-8 assay. Both NIH-3T3 and HELF cells were exposed to H2O2 (25, 50, 100, 150 or 200mM) for 1h or
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(Figure 3A).
Chen et al. (42) demonstrated that JWA interacts with
XRCC1 in intact NIH-3T3 cells. Moreover, XRCC1, as
a scaﬀold protein, interacts with LigIII and PARP-1
to assemble a DNA repair complex for BER (47).
In the present study, co-immunoprecipitation assays
were employed to establish whether JWA is involved
in the BER protein complex. As shown in Figure 3B
and Supplementary Figure S1, JWA interacts with
XRCC1, LigIII and PARP-1, not only in intact NIH-
3T3 cells, but also in treated cells (100mMH 2O2 for
30min). Moreover, the amount of the proteins (JWA-
XRCC1 and JWA-LigIII) in the extracts of impaired
cells was markedly enhanced compared with those in
intact cells. However, no increased JWA-PARP-1 complex
in the H2O2-treated cells was found. These data indicated
that JWA may be a component of BER protein complex
in response to DNA damage.
Oxidative damage inducesJWA translocation into
thenucleus
In response to DNA-strand breaks, activated PARP-1 cat-
alyzes the transfer of the ADP-ribose moiety from NAD
+
to a number of protein acceptors, resulting in PAR accu-
mulation in the SSB sites (11). These steps are required
for the recruitment of scaﬀold protein XRCC1 to DNA
damage sites. In our study, immunoﬂuorescent micro-
scopy was used to determine the intracellular distribution
of JWA in NIH-3T3 cells with or without H2O2 treatment.
As shown in Figure 4, in addition to the expected uniform
cytoplasmic distribution, JWA was also present in small
intense regions of the nucleus in untreated cells; however,
the PAR was not detected in untreated cells (Figure 4A).
After exposure to 10mM H2O2 for 15min, most of the
JWA in the cells were translocated into the nucleus. We
also observed that JWA is rapidly assembled into discrete
nuclear foci after oxidative DNA damage at sites of PAR
synthesis (Figure 4A). Moreover, JWA foci were co-loca-
lized with XRCC1 foci after H2O2 treatment (Figure 4B).
To exclude the nonspeciﬁcity of the JWA and XRCC1
antibodies, we observed the intracellular distribution
JWA and XRCC1 in JWA knockdown cells. As shown
in Supplementary Figure S2, knockdown of JWA
decreased the XRCC1 staining in untreated cells (as indi-
cated by the yellow arrow in Figure S2A) and in the
impaired cells (10mM H2O2 for 15min) (as indicated by
the single yellow arrow in Figure S2B; the double yellow
arrows denote that the JWA was not decreased in the cell
due to ineﬀective transfection). We also found that a large
proportion of the GFP-JWA in the cells was translocated
into the nucleus and co-localized with RFP-XRCC1 foci
after H2O2 treatment (Figure 4C).
To conﬁrm the observed translocation of JWA from the
cytoplasm to the nucleus following H2O2 treatment, cells
were subfractionated and immunoblotted with anti-JWA
antibody. As expected, JWA underwent nuclear transloca-
tion under oxidative stress, with the amount of JWA in the
nucleus increased during the ﬁrst 30min following with-
drawal of the H2O2; at the same time, other DNA repair
enzymes including XRCC1 and LigIII, were also elevated
in the nucleus. Interestingly, JWA returned back to the
cytoplasm by 60min in the repair process. These changes
in JWA distribution paralleled changes in XRCC1 and
LigIII (Figure 4D).
It was unclear how JWA was being translocated into
the nucleus without a classic nuclear translocation signal
(NLS). We postulated that JWA is recruited into the
nucleus either by an unknown target of XRCC1 or
XRCC1 itself right after its synthesis in the cytoplasmic
ribosomes as knocking down XRCC1 inhibited JWA
translocation into the nucleus. Since XRCC1 is known
to play a role as a scaﬀold in the BER complex, we ini-
tially determined whether XRCC1 could transport JWA
into the nucleus after DNA damage. An siRNA was used
to downregulate XRCC1, then the expression and distri-
bution of JWA was measured. Seventy-two hours after
transfection of NIH-3T3 cells with XRCC1 siRNA, we
observed a 70% and 90% reduction in XRCC1 in the
whole-cell lysates of untreated and H2O2-treated NIH-
3T3 cells, respectively, whereas JWA level in these extracts
was unaltered (Figure 4E). However, the nuclear JWA
was markedly reduced in the XRCC1 knockdown
cells (Figure 4F). Interestingly, cytoplasmic JWA
tended to be increased by knockdown of XRCC1
(Figure 4F). Additionally, nuclear LigIII, which is stabi-
lized by XRCC1, was decreased when XRCC1 was
knocked down.
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Figure 3. JWA as a novel BER protein is involved in the SSBR path-
way. (A) The expression levels of BER complex components (APE1,
XRCC1, LigIII) during DNA repair after H2O2 treatment (100mM,
30min) in JWA stable knockdown cells and vector control cells were
detected by immunoblotting. The indicated time points represent the
amount of time after withdrawal of the DNA-damaging agent. Whole-
cell extracts were prepared for immunoblotting, and equal protein load-
ing was conﬁrmed by comparison with b-actin. (B) The NIH-3T3 cells
were pretreated with 100mMH 2O2 for 30min and endogenous protein–
protein interaction between JWA and XRCC1 was determined by
immunoprecipitation (IP) with JWA or XRCC1 antibodies followed
by immunoblotting. IgG was used as negative control for IP.
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To address how JWA downregulates XRCC1, the level of
XRCC1 mRNA in JWA knockdown and control NIH-
3T3 cells was determined. Quantitative RT-PCR results
showed that the levels of JWA and XRCC1 mRNA were
increased 2.3-fold and 1.5-fold in control cells in response
of H2O2 treatment, respectively. In contrast, XRCC1
mRNA expression was reduced in JWA knockdown
cells, and there was no signiﬁcant increase in either JWA
or XRCC1 mRNA expression following H2O2 treatment
(Figure 5A).
It has been reported that transcription factor E2F1
binds to the XRCC1 promoter region and regulates
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Figure 4. H2O2 triggers JWA translocation into the nucleus and co-localization with the components of BER complex on DNA damage sites. (A)
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JWA or an RFP-XRCC1 plasmid. After 48h, the transfected cells were split, grown on coverslips, exposed to H2O2 as in (A). Representative images
were photographed and colored using a Zeiss LSM 510 confocal microscope system. (D) The intracellular distribution of JWA and the components
of BER complex during DNA repairing after H2O2 exposure. NIH-3T3 cells were treated with 100mMH 2O2 for 30min and further cultured in
H2O2-free medium to allow for DNA repair. Cytoplasmic and nuclear extracts were prepared, and western blotting were employed to detect the
expression of XRCC1, LigIII, PARP-1 and JWA. Aldolase and histone H1 were used as the cytoplasmic and nuclear loading controls, respectively.
The experiments were repeated twice with similar results. (E) XRCC1 does not aﬀect the expression of JWA. NIH-3T3 cells were transfected with a
control siRNA pool or a XRCC1 siRNA pool to knockdown endogenous XRCC1. After 72h, the transfected cells were treated with or without
100mMH 2O2 for 30min. Whole-cell lysates were collected for detection of target proteins, including XRCC1 and JWA by immunblotting. b-Actin
was used for the protein loading control. (F) XRCC1 induced subcellular redistribution of JWA and LigIII. The treatments were the same as in (E).
Western blot analysis was performed to analyze XRCC1, LigIII and JWA in the cytoplasmic and nuclear extracts. Aldolase and histone H1 were
used as the cytoplasmic and nuclear loading controls, respectively.
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Figure 5. JWA regulates XRCC1 transcription via the MAPK signaling pathway and E2F1. (A) JWA knockdown in NIH-3T3 cells signiﬁcantly
inhibits H2O2-induced transcription of XRCC1. NIH-3T3 cells were transfected with a control shRNA or a JWA shRNA plasmid, followed by
treatment with or without 100mMH 2O2 for 30min. Levels of JWA and XRCC1 transcription were detected by quantitative RT-PCR, and GAPDH
was used as an endogenous control to normalize the diﬀerences in the amount of total RNA in each sample. (B) The E2F1-binding domain in the
XRCC1 promoter is required for the JWA-mediated increase in XRCC1 expression after exposure to H2O2. NIH-3T3 cells were co-transfected with
either control shRNA or JWA shRNA, together with the XRCC1 promoter-reporter (–881 to+158, containing E2F1-binding domain) or an E2F1-
binding site deleted XRCC1 promoter-reporter (E2F1-XRCC1, –776 to+158). After 24h, the transfected cells were cultured with or without
100mMH 2O2 for 30min, then the reporter activity was examined. The means SD of triplicate experiments are shown.
 P<0.05. (C) JWA is
required for H2O2-induced E2F1 expression. NIH-3T3 cells were transfected with a control shRNA or JWA shRNA plasmid. Then 48h after
transfection, the cells were treated with or without 100mMH 2O2 for 30min, and nuclear lysates were collected for detection of E2F1 by immun-
blotting. Histone H1 was used as the nuclear protein loading control. (D) JWA alters the aﬃnity of E2F1 for the XRCC1 promoter, as detected by
EMSA. The nuclear protein extracts of the NIH-3T3 cells (with or without treatment with 100mMH 2O2 for 30min) were incubated with a biotin-
labeled double-strand oligonucleotide probe of the XRCC1 promoter region, which contains an E2F1-binding domain (–826 to –797bp). JWA
shRNA transient transfection was used to knock down JWA expression in the NIH-3T3 cells. The DNA–protein complex (shift band) or DNA–
protein–antibody complex (supershift band) is indicated by an arrow. Lane 1 contains no nuclear extracts. All other lanes contain 0.5-mg nuclear
extracts except lanes 3 and 6 which contain 1-mg nuclear extracts. Lane 8 represents competition analysis using 100-fold unlabeled probes. The
supershift band was observed when the E2F1 antibody was added (lane 9) and IgG was used as negative control for supershift (lane 10). (E) JWA
regulates E2F1 expression via MAPK signaling cascades. JWA shRNA and control shRNA plasmids were transiently transfected into NIH-3T3 cells.
After 46h, the control shRNA vector transfected cells were incubated with 20mM of PD98059 or 10mM U0126 for another 2h. All transfected cells
were then cultured for another 30min in the presence or absence of H2O2 (100mM), and the whole-cell lysates were collected for western blotting.
1944 Nucleic Acids Research, 2009, Vol. 37,No. 6XRCC1 transcription (33). To examine whether JWA reg-
ulates XRCC1 promoter transcriptional activity via E2F1,
a JWA shRNA or control shRNA were cotransfected
together with an XRCC1 promoter-luciferase reporter
including (E2F1-XRCC1) or lacking the E2F1-binding
site (iE2F1-XRCC1). The luciferase activity of the
XRCC1 promoter-luciferase reporter (E2F1-XRCC1)
increased following exposure to H2O2, whereas the activ-
ity was signiﬁcantly reduced both prior to and following
H2O2 exposure in JWA konckdown cells. The luciferase
activity of the iE2F1-XRCC1 promoter-luciferase repor-
ter was signiﬁcantly attenuated compared with that of the
E2F1-XRCC1 promoter-luciferase reporter. In addition,
the activity of the iE2F1-XRCC1 promoter did not
change in response to either H2O2 treatment or knock-
down of JWA (Figure 5B).
To conﬁrm whether JWA regulates E2F1 expression at
protein levels, we examined the E2F1 protein expression
by western blotting. Our results showed that knockdown
of JWA signiﬁcantly decreased E2F1 protein level in both
control and H2O2-treated NIH-3T3 cells (Figure 5C). In
addition, EMSA was performed to determine whether
JWA aﬀects the aﬃnity of E2F1 for binding to the
XRCC1 promoter. As shown in Figure 5D, the proteins
in the nuclear extracts of NIH-3T3 cells formed a complex
with the labeled probe (XRCC1 –826 to –797-bp promoter
region), which included the E2F1-binding sites. The shift
band was eliminated by the addition of 100-fold unlabeled
probe. When an antibody against E2F1 was added, a spe-
ciﬁc supershift band was observed, while no supershift
complex was formed when a control IgG was substituted.
The shift band and the supershift band were not aﬀected
by the addition of the same fold unlabeled mutated probe
(Supplementary Figure S3). Furthermore, the DNA–
protein complex or DNA–protein–E2F1 antibody com-
plex was more abundant in the nuclear extracts from
normal cells than from JWA knockdown cells
(Supplementary Figure S3). We also found that the
amount of DNA–protein binding increased further when
more nuclear extracts from normal cells, but not from
JWA knockdown cells, were added to the complex
(Figure 5D). Following H2O2 stimulation, the aﬃnity of
E2F1 binding to the labeled probe was increased in the
control cells (Figure 4D, lanes 2 and 4), but not in JWA
knockdown cells (Figure 5D, lanes 5 and 7). These data
provide further evidence that knockdown of JWA down-
regulates E2F1 levels and decreases the aﬃnity of E2F1
binding to the XRCC1 promoter, resulting in decreased
expression of XRCC1.
It was reported that E2F1 is located downstream of the
MAPK signaling pathway and is activated by activation
of the PKC/Raf/MEK/ERK pathway (31,32). Chen et al.
(37) previously showed that phosphorylation of MEK-
ERK, but not Raf, was completely blocked in JWA
knockdown cells. Therefore, we postulated that JWA
may activate E2F1 via the MAPK cascade. To test this
hypothesis, western blot analysis for ERK and phos-
phorylated ERK expression following DNA damage in
cell culture models was conducted. As shown in
Figure 5E, phosphorylated ERK was detected following
H2O2 treatment. As expected, both E2F1 and XRCC1
levels were enhanced following ERK activation.
However, the activation of ERK was signiﬁcantly blocked
in JWA knockdown cells, and this was accompanied by
decreased expression of E2F1 and XRCC1. In order to
conﬁrm the importance of ERK signaling in H2O2-
induced upregulation of E2F1 and XRCC1, the MEK1/
2 inhibitors PD98059 and U0126 were used. Both U0126
and PD98059 led to a substantial decrease in H2O2-
induced phosphorylation of ERK, which subsequently
reduced the H2O2-induced E2F1 and XRCC1 expression
(Figure 5E). These data suggest that knockdown of JWA
suppresses MAPK signaling and reduces E2F1 protein
levels, leading to a decreased aﬃnity of E2F1 for binding
to the XRCC1 promoter, resulting in decreased XRCC1
transcription.
JWAisrequired formaintaining thestability of the
XRCC1 protein
It was previously demonstrated that XRCC1 levels were
reduced in stable JWA knockdown cells (42). We therefore
postulated that JWA may be required for XRCC1 stabi-
lity. When the cells were treated with CHX, an inhibitor of
protein synthesis, we found that knockdown of JWA pro-
moted the degradation of both endogenous XRCC1 and
LigIII proteins in NIH-3T3 cells (Figure 6A and B). To
determine whether the ubiquitin-proteasome pathway is
responsible for XRCC1 degradation, cells were treated
with the proteasome inhibitor MG132. We observed that
loss of XRCC1 expression in JWA knockdown cells was
inhibited by pretreatment with 10mM MG132 for 4h
(Figure 6C). Similar eﬀects were observed for LigIII
(Figure 6C), suggesting that JWA inhibits the proteasomal
degradation of these proteins. In order to conﬁrm these
data, an exogenous RFP-XRCC1 plasmid was transfected
into stable selected vector control cells or KD-JWA cells
with or without MG132 pretreatment. The transfected
exogenous XRCC1 was also destabilized in JWA deﬁcient
cells (Figure 6D). The decreased expression of endogenous
and exogenous XRCC1 in JWA knockdown cells was
conﬁrmed by western blotting (Figure 6E). However, the
reduction in XRCC1 expression could be prevented by
pretreatment with MG132 (Figure 6D and E).
To test whether XRCC1 degradation by the proteasome
is initiated by XRCC1 ubiquitination, JWA shRNA-
and control shRNA-transfected cells were cultured in the
presence or absence of MG132. We found that XRCC1
was ubiquitinated in the presence of MG132, and that
JWA depletion enhanced the ubiquitination of XRCC1
(Figure 6F). Furthermore, LigIII was immunoprecipitated
by the anti-XRCC1 antibody in lysates from JWA-
depleted cells, although the interaction was apparently
decreased compared to control cells. However, the level
of LigIII was preserved when the JWA knockdown cells
were pretreated with MG132 (Figure 6F).
DISCUSSION
JWA was originally recognized as an all-trans-retinoic
acid responsive and cytoskeleton-associated gene (36).
Later Zhu et al. (40,41) noted that JWA was actively
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Figure 6. JWA is required for maintaining the stability of the XRCC1 protein. (A) JWA deﬁciency signiﬁcantly enhanced the degradation of XRCC1 and
LigIII. NIH-3T3 cells were transfected with JWA shRNA or the corresponding empty vector for 48h, followed by exposure to cycloheximide (CHX)
(50mg/ml) for various time periods. Target proteins in whole-cell lysates were detected by immunoblotting using antibodies against XRCC1, LigIII and
JWA. (B) The intensity of the XRCC1 and LigIII protein bands in (A) were analyzed by densitometry, after normalization to the corresponding b-actin
level. The means   SD are from three independent experiments. (C) The proteasome mediates the degradation of XRCC1 and LigIII. NIH-3T3 cells were
transfected with JWA shRNA or the control vector. Forty-four hours later, cells were incubated with or without of MG132 (10mM) for 4h, then the cells
were cultured for another 30min with or without 100mMH 2O2. Cell lysates were used for immunoblotting with antibodies against XRCC1, LigIII and
JWA. b-Actin was used as a loading control. (D) An RFP-XRCC1 plasmid was transiently transfected into stable selected EGFP-C1 vector control or
KD-JWA NIH-3T3 cells. Forty-four hours later, the cells were incubated with or without of MG132 (10mM) for 4h. The cells were then ﬁxed in
methanol/acetone and counterstained with DAPI. The expression of RFP-XRCC1 in the cells (red) was observed under a ﬂuorescent microscope. The
nucleus of the cells was indicated by DAPI (blue). (E) NIH-3T3 or KD-JWA cells were transiently transfected with RFP-XRCC1 plasmid for 44h,
incubated with MG132 (10mM) for 4h, and western blotting was performed to conﬁrm the levels of endogenous XRCC1 (lower molecule band) and
exogenous XRCC1 (RFP-XRCC1). (F) Knocking down JWA results in the ubiquitylation and degradation of XRCC1. NIH-3T3 cells were transfected
with JWA shRNA or the control vector. Forty-four hours later, the cells were incubated with or without of MG132 (10mM) for another 48h. Cell lysates
were used for IP with the XRCC1 antibody and then blotted for XRCC1, LigIII and ubiquitin. Western blotting for JWA and b-actin in whole-cell lysates
was utilized to check the JWA knockdown eﬃciency and to ensure equal protein loading.
1946 Nucleic Acids Research, 2009, Vol. 37,No. 6regulated by environmental stressors such as heat shock
and oxidative stress, thereby suggesting that JWA might
be a functionally active gene. JWA may play diﬀerent bio-
logical functions under normal and diﬀerent stress condi-
tions due to its subcellular localization. Watabe et al. (48)
demonstrated that the glutamate transport-associated pro-
tein for EAAC1 (GTRAP3-18), a homolog of JWA pro-
tein identiﬁed in rat, to interact with EAAC1at the plasma
membrane and thereby regulate neuronal glutathione
levels. Our recent data showed that JWA was involved
in cellular responses to chemically induced oxidative
stress and also participated in the protection of cells
from stress-induced DNA damage (42). The mammalian
JWA proteins are highly conserved within their deﬁned
N- and C-terminal domains, and JWA-like proteins are
also present in a wide range of eukaryotes from ﬂies
to human beings (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=homologene), indicating that JWA plays an
important, evolutionarily conserved role. In this study,
JWA, a novel component of the DNA damage response,
was found to have a considerable impact in the repair of
DNA SSBs.
Our previous data provided direct proof that JWA is
required for DNA-strand break resealing by comet assay
and showed that reduced JWA levels partially inhibited
DNA rejoining (42). Here, additional phenotypic evidence
was provided conﬁrming that JWA is essential for DNA
damage repair. First, the HCR assay showed that endo-
genous JWA is required for the removal of H2O2-induced
DNA lesions. Second, the intracellular NAD(P)H assay
showed that DNA damage was greater in JWA-depleted
cells than in JWA wild-type cells. Third, downregulation
of JWA resulted in increased sensitivity of both mouse and
human cell lines to H2O2 and MMS, which is in agreement
with previous studies indicating that XRCC1
–/– CHO cells
or RNAi-mediated XRCC1 knockdown human cell lines
are hypersensitive to DNA-damaging agents (23,26,49).
These ﬁndings suggested that JWA mediates protective
eﬀects in cells in response to oxidative stresses.
BER is a ubiquitous mechanism for removing damaged
DNA induced by spontaneous chemical reactions, ROS
and a variety of environmental genotoxicants (1). Many
repair enzymes are involved in this process, and a major
characteristic of these repair proteins is the formation of
distinct foci which persist for a period of time after DNA
damage (50,51). At the earliest stage of SSBR, PARP-1
rapidly binds to SSBs and is thereby activated, leading to
the rapid formation of poly (ADP-ribose) polymer (PAR)
nuclear foci, followed by the appearance of XRCC1
nuclear foci at the same sites (14). In the present study,
we revealed that a prominent feature of JWA is its ability
to rapidly translocate into the nucleus and transiently
assemble into discrete nuclear foci after oxidative DNA
damage. The complete overlap of JWA localization with
PAR and XRCC1 provides important clues for its func-
tion in DNA damage repair. It seems that these foci rep-
resent aggregates of proteins to facilitate DNA repair or
assist in signaling that DNA damage is present (52).
Moreover, the nuclear proteins in DNA repair foci have
been immensely useful in the identiﬁcation of new factors
involved in DNA repair (53). These ﬁndings suggest that
JWA is likely a novel DNA repair molecule.
A feature of mammalian SSBR appears to be the
employment of protein–protein interactions to stimulate
individual component steps and/or the overall repair reac-
tion (16). Arguably, the most intriguing SSBR protein in
this respect is XRCC1, a scaﬀold protein that interacts
with PARP-1 and LigIII via its two BRCA1 carboxyl-
terminal (BRCT) domains, denoted BRCT I and II,
respectively (54). Our study revealed that JWA interacts
with XRCC1, PARP-1 and LigIII in normal or stressed
conditions, identifying JWA as a component of BER pro-
tein complexes. Furthermore, the interaction of JWA and
XRCC1 may explain how JWA can translocate to the
nucleus despite its lack of a classic NLS domain. It was
presumed that JWA interacts with XRCC1, which con-
tains a NLS at positions 239 to 266 in its amino acid
sequence (54), and be subsequently transported into
nucleus by XRCC1 following DNA damage. Notably,
our studies showed that siRNA-mediated downregulation
of XRCC1 inhibited JWA translocation into the nucleus.
Despite the importance of JWA and XRCC1 in SSBR, it
is possible that additional mechanisms may be involved in
this process. For example, post-translational modiﬁca-
tions, such as phosphorylation (55) and mono-ubiquityla-
tion (56), may also inﬂuence a protein’s localization. There
are two potential phosphorylation sites (serine residues)
and 10 ubiquitylation sites (lysine residues) in the JWA
protein. Future studies will be necessary to determine
which, if any, of these sites is important.
Current evidence suggests that DNA damage activates
signaling pathways for damage recognition, DNA repair,
cell-cycle progression and apoptosis (57,58). For example,
generation of H2O2 is required for platelet-derived growth
factor (PDGF) signal transduction (59); the EGFR (epi-
dermal growth factor receptor)-MAPK signaling cascade
appears to regulate the expression of XRCC1 in prostate
carcinoma cells to repair DNA-strand breaks induced by
radiation (30); and E2F1 is activated by the MAPK sig-
naling cascade following DNA damage (31) and subse-
quently phosphorylated and stabilized via ATM/ATR
(60) and Chk2 dependent pathways (61). Our present
data conﬁrmed that inhibition of ERK1/2 activity elimi-
nated the H2O2-induced upregulation of the expression of
E2F1 and XRCC1. We also found that knocking down
JWA resulted in inactivation of the MEK-ERK signaling
pathway and downregulation of E2F1. Since many repair
genes have been identiﬁed as putative E2F1 targets,
including TP53 (62,63) and XRCC1 (33), our study indi-
cates that knockdown of JWA not only reduces E2F1
expression, but also decreases its aﬃnity for binding to
the XRCC1 promoter, leading to decreased transcription
of XRCC1. Our previous and present studies also deﬁned
a novel signaling pathway wherein intracellular H2O2 trig-
gers NF1 activation and binding to the JWA promoter
region (42), resulting in increased JWA transcription, acti-
vating E2F1 and, subsequently, XRCC1 via the MAPK
signaling cascades. This process facilitates DNA SSBR
(Figure 7). However, recent publications have suggested
that XRCC1 is phosphorylated by protein kinases DNA-
PK (64) and CK2 (65) to enhance DNA repair and genetic
Nucleic Acids Research,2009, Vol.37, No. 6 1947stability. The role of JWA and a possible crosstalk
between the MAPK and DNA-PK/CK2 pathways in
XRCC1 activation needs to be examined in future studies.
XRCC1 not only interacts with enzymes during each
step of BER, but also coordinates several repair proteins
to enhance DNA-repair eﬃcacy. It was reported that the
formation of DNA-repair complexes on damaged DNA
requires XRCC1 to act as a scaﬀold to stabilize the BER
proteins, and that when the proteins are no longer needed
for the repair complex, they are ubiquitylated by the E3
ubiquitin ligase CHIP and degraded by the proteasome
(34). It was suggested that ubiquitination sites on the
BER proteins within repair complexes may be masked
by XRCC1, and that the absence of XRCC1 will immedi-
ately lead to their degradation (34). However, how the
stability of XRCC1 itself is regulated is not clear. Our
study demonstrated that JWA is a novel component of
BER complex that can stabilize XRCC1. Interestingly,
the half-life of both XRCC1 and its partner LigIII were
shortened in JWA-depleted cells. Moreover, when JWA
is absent, XRCC1 is rapidly degraded through the
ubiquitin-proteasome pathway. Therefore, it is reasonable
to presume that JWA might be the candidate protein that
can mask the ubiquitlylation sites in XRCC1, thus stabi-
lizing XRCC1 (Figure 7).
In summary, our present results indicate that JWA, a
novel component of the BER complex which is recruited
by XRCC1 to the DNA damage sites, mediates the repair
of DNA damage induced by oxidative stress via
activating the expression of XRCC1 through MAPK-
E2F1 signaling pathway and protecting XRCC1 from
ubiquitin-proteasome degradation. Our study not only
provides novel mechanistic insights into the role of JWA
in the regulation of BER, but further deﬁnes the involve-
ment of XRCC1 in the SSBR/BER process.
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